MiMedx projects net sales of $250-260 million for 2026, targeting an adjusted EBITDA margin of more than 20% with Sanra.
MiMedx projects net sales of $250-260 million for 2026, targeting an adjusted EBITDA margin of more than 20% with Sanra.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in